Articles By Anuja Singh

Could the Algen Biotechnologies – AstraZeneca $555 Million AI-Driven Drug-Discovery Pact Redefine How Immunology…

Key Highlights / Executive Take-aways: Strategic Significance of the PartnershipThe alliance between Algen Biotechnologies and AstraZeneca marks a…

ByByAnuja SinghOct 26, 2025
Can Takeda and Nabla Bio’s $1 Billion AI Alliance Redefine the Future of Protein…

Key Highlights: AI Takes Center Stage in Takeda’s R&D RebootAfter narrowing its research focus to small molecules, biologics,…

ByByAnuja SinghOct 26, 2025
Could Cohere’s New Paris Office Accelerate AI Adoption Across Europe’s Healthcare and Biopharma Sector?

Key Insights: Expanding Footprint in Europe Cohere, a Canadian AI firm known for developing large language models and…

ByByAnuja SinghSep 16, 2025
Could Aiforia and Siemens Healthineers Transform Digital Pathology Across Europe With AI?

Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration with Siemens Healthineers…

ByByAnuja SinghSep 16, 2025
Can Ant Group’s AQ AI Health App Redefine Access to Quality Care for 140…

Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…

ByByAnuja SinghSep 16, 2025
Can GHX’s AI-Driven Supply Chain Solutions Transform How Hospitals Tackle Disruptions?

Key Highlights AI reshaping healthcare supply chains: Unlike retail or tech, healthcare requires flawless delivery—any delay can directly…

ByByAnuja SinghSep 16, 2025
Image Not Found
Could the Algen Biotechnologies – AstraZeneca $555 Million AI-Driven Drug-Discovery Pact Redefine How Immunology…

Key Highlights / Executive Take-aways: Strategic Significance of the PartnershipThe alliance between Algen Biotechnologies and AstraZeneca marks a…

ByByAnuja SinghOct 26, 2025
Can Takeda and Nabla Bio’s $1 Billion AI Alliance Redefine the Future of Protein…

Key Highlights: AI Takes Center Stage in Takeda’s R&D RebootAfter narrowing its research focus to small molecules, biologics,…

ByByAnuja SinghOct 26, 2025
Could Cohere’s New Paris Office Accelerate AI Adoption Across Europe’s Healthcare and Biopharma Sector?

Key Insights: Expanding Footprint in Europe Cohere, a Canadian AI firm known for developing large language models and…

ByByAnuja SinghSep 16, 2025
Could Aiforia and Siemens Healthineers Transform Digital Pathology Across Europe With AI?

Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration with Siemens Healthineers…

ByByAnuja SinghSep 16, 2025
Can Ant Group’s AQ AI Health App Redefine Access to Quality Care for 140…

Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…

ByByAnuja SinghSep 16, 2025
Can GHX’s AI-Driven Supply Chain Solutions Transform How Hospitals Tackle Disruptions?

Key Highlights AI reshaping healthcare supply chains: Unlike retail or tech, healthcare requires flawless delivery—any delay can directly…

ByByAnuja SinghSep 16, 2025
Scroll to Top